Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Department of Clinical Development, 3D Medicines Inc.

2 abstracts

Abstract
Efficacy and safety of combination therapy with envafolimab and lenvatinib in patients with endometrial cancer after failure of first-line platinum-based therapy.
Org: Ganzhou Cancer Hospital, Department of Gynecologic Oncology, Fujian Provincial Cancer Hospital, Yueyang Central Hospital, Department of Clinical Development, 3D Medicines Inc.,
Abstract
Final three-year follow-up analysis of phase I/II study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma.
Org: Department of Neurosurgery, Peking Union Medical College Hospital, Beijing, China, Osaka International Cancer Institute, Osaka, Japan, Department of Neurosurgery and Neuro-Oncology, National Cancer Center Research Institute, Tokyo, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Kyorin University Faculty of Medicine,